Dr. Jay Bhattacharya, a Stanford professor of health policy, appears before the Senate HELP committee, which will vet his nomination to become the next director of the National Institutes of Health.
Dr. Francis Collins is leaving the National Institutes of Health, where he served as director from 2009 to 2021. The agency is facing cutbacks and restrictions under the Trump administration.
Iowa has the second highest incidence rate of cancer in the country, and it is already feeling Trump's cuts to the workforce and research institutions trying to solve the rural cancer problem.
Thousands of grant applications had been stalled when the Trump administration blocked the National Institutes of Health from posting notices to the Federal Register.
Researchers say the Trump administration's plan to slash payments for indirect costs will hamper new medical science. One example? A lab studying respiratory viruses faces losing half its staff.
The National Institutes of Health had to stop considering new grant applications, delaying funding for research into diseases ranging from heart disease and cancer to Alzheimer's and allergies.
Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth. Dr. Jay Bhattacharya, NIH nominee, will shed stock in Walmart and Nvidia.
What do National Institutes of Health funding cuts mean for universities? We ask Holden Thorp, editor-in-chief of the journal Science and former University of North Carolina at Chapel Hill chancellor.
There's widespread confusion and fear among scientists and doctors on the sprawling National Institutes of Health campus and at institutions dependent on the agency's funding.
Research and basic information on subjects ranging from tuberculosis surveillance to adolescent health disappeared from federal health agency websites.
An email obtained by NPR says NIH employees are subject to a travel freeze and offers of employment are being rescinded. Scientists worry about disruptions to critical research.
Dr. Jay Bhattacharya, a Stanford health researcher, is in line to lead the National Institutes of Health. Early in the pandemic he argued against lockdowns and focusing on people at highest risk.
The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.
